Mark A Glickman - Net Worth and Insider Trading
Mark A Glickman Net Worth
The estimated net worth of Mark A Glickman is at least $2,873 dollars as of 2024-05-18. Mark A Glickman is the Co-CEO of TherapeuticsMD Inc and owns about 1,294 shares of TherapeuticsMD Inc (TXMD) stock worth over $2,873. Details can be seen in Mark A Glickman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark A Glickman has not made any transactions after 2022-12-06 and currently still holds the listed stock(s).
Transaction Summary of Mark A Glickman
Mark A Glickman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark A Glickman owns 4 companies in total, including Esperion Therapeutics Inc (ESPR) , Old API Wind-down Ltd (ARLZQ) , and TherapeuticsMD Inc (TXMD) among others .
Click here to see the complete history of Mark A Glickman’s form 4 insider trades.
Insider Ownership Summary of Mark A Glickman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ESPR | Esperion Therapeutics Inc | 2018-12-20 | Chief Commercial Officer |
| ARLZQ | Old API Wind-down Ltd | 2018-03-19 | Chief Commercial Officer |
| TXMD | TherapeuticsMD Inc | 2022-12-06 | Chief Business Officer |
 | | 2023-05-11 | director |
Mark A Glickman Latest Holdings Summary
Mark A Glickman currently owns a total of 1 stock. Mark A Glickman owns 1,294 shares of TherapeuticsMD Inc (TXMD) as of December 6, 2022, with a value of $2,873.
Latest Holdings of Mark A Glickman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TXMD | TherapeuticsMD Inc | 2022-12-06 | 1,294 | 2.22 | 2,873 |
Holding Weightings of Mark A Glickman
Mark A Glickman Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark A Glickman has made a total of 1 transactions in TherapeuticsMD Inc (TXMD) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in TherapeuticsMD Inc is the sale of 440 shares on December 6, 2022, which brought Mark A Glickman around $2,165.
Insider Trading History of Mark A Glickman
- 1
Mark A Glickman Trading Performance
Mark A Glickman Ownership Network
Mark A Glickman Owned Company Details
What does Esperion Therapeutics Inc do?
Who are the key executives at Esperion Therapeutics Inc?
Mark A Glickman is the Chief Commercial Officer of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Commercial Officer Eric Warren , Chief Operating Officer Sheldon L. Koenig , and Chief Medical Officer Joanne M. Foody .
Esperion Therapeutics Inc (ESPR) Insider Trades Summary
Over the past 18 months, Mark A Glickman made no insider transaction in Esperion Therapeutics Inc (ESPR). Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 7,644 shares made by Eric Warren , a net sale of 9,821 shares made by Joanne M. Foody , and a net purchase of 7,560 shares made by Sheldon L. Koenig .
In summary, during the past 3 months, insiders sold 0 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,542 shares of Esperion Therapeutics Inc (ESPR) were sold and 59,611 shares were bought by its insiders, resulting in a net purchase of 22,069 shares.
Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Esperion Therapeutics Inc Insider Transactions
Mark A Glickman Mailing Address
Above is the net worth, insider trading, and ownership report for Mark A Glickman. You might contact Mark A Glickman via mailing address: C/o Esperion Therapeutics, Inc., 3891 Ranchero Drive, Suite 150, Ann Arbor Mi 48108.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
